Last reviewed · How we verify

NCT06989320

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Recruiting now NA Last updated 31 May 2025
What this trial tests

NA trial testing Low-oxalate diet and glycolate dosing in Kidney Stones in 80 participants. Currently enrolling.

Timeline
27 May 2025
Primary endpoint
31 December 2030
31 December 2031

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment80
Start date27 May 2025
Primary completion31 December 2030
Estimated completion31 December 2031
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 80, any sex, with Kidney Stones or Kidney Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Kidney Stones

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06989320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing